Dr. Daphna Laifenfeld: Antidepressants, Neuroplasticity, and NeuroKaire Technology

Dr. Daphna Laifenfeld is a pioneering leader in precision medicine and digital health. With a Ph.D. in Medical Sciences from the Technion and postdoctoral training at Harvard, she laid the groundwork in neurobiology and neurodegeneration. She later headed biomarker and diagnostics efforts in top-tier pharma at Teva and Selventa, then served as Chief Scientific Officer at Ibex Medical Analytics, where her team developed AI-driven cancer diagnostics used globally. In 2017, she co‑founded Genetika+ (now NeuroKaire), which deploys a novel “brain‑in‑a‑dish” platform combined with AI to personalize treatment choices in mental health. Today, as CSO and Co‑Founder, Daphna continues to steer breakthroughs in depression care and beyond.

https://www.neurokaire.com/

Disclaimer: The views and opinions expressed by the guest speaker on this episode are solely those of the guest. The content shared is intended for informational purposes only and should not be construed as professional advice or endorsement.